Biosergen AB (BIOSGN.ST)

SEK 0.51

(-5.9%)

EBITDA Summary of Biosergen AB

  • Biosergen AB's latest annual EBITDA in 2023 was 228 Thousand SEK , up 100.67% from previous year.
  • Biosergen AB's latest quarterly EBITDA in 2024 Q2 was -5.72 Million SEK , up 15.74% from previous quarter.
  • Biosergen AB reported an annual EBITDA of -39.98 Million SEK in 2022, up 0.25% from previous year.
  • Biosergen AB reported an annual EBITDA of - SEK in 2021, down -447.35% from previous year.
  • Biosergen AB reported a quarterly EBITDA of -5.72 Million SEK for 2024 Q2, up 15.74% from previous quarter.
  • Biosergen AB reported a quarterly EBITDA of -8.03 Million SEK for 2023 Q2, down -59.83% from previous quarter.

Annual EBITDA Chart of Biosergen AB (2023 - 2019)

Historical Annual EBITDA of Biosergen AB (2023 - 2019)

Year EBITDA EBITDA Growth
2023 228 Thousand SEK 100.67%
2022 -39.98 Million SEK 0.25%
2021 - SEK -447.35%
2020 -6.72 Million SEK 4.49%
2019 -187.98 Thousand SEK 0.0%

Peer EBITDA Comparison of Biosergen AB

Name EBITDA EBITDA Difference
Alligator Bioscience AB (publ) -237.61 Million SEK 100.096%
Ziccum AB (publ) -20.34 Million SEK 101.121%
Modus Therapeutics Holding AB (publ) 2000.00 SEK -11300.0%
BioArctic AB (publ) 275.38 Million SEK 99.917%
Sprint Bioscience AB (publ) -2.08 Million SEK 110.962%
Mendus AB (publ) -97.84 Million SEK 100.233%
Genovis AB (publ.) 64.57 Million SEK 99.647%
Intervacc AB (publ) -68.98 Million SEK 100.331%
QuiaPEG Pharmaceuticals Holding AB (publ) -13.43 Million SEK 101.698%
Active Biotech AB (publ) -43.88 Million SEK 100.52%
Magle Chemoswed Holding AB (publ) 31.4 Million SEK 99.274%
Bio-Works Technologies AB (publ) -54.8 Million SEK 100.416%
Aptahem AB (publ) -10 Million SEK 102.278%
Vicore Pharma Holding AB (publ) -317.46 Million SEK 100.072%
Kancera AB (publ) -61.88 Million SEK 100.368%
Infant Bacterial Therapeutics AB (publ) 11.54 Million SEK 98.026%
Fluicell AB (publ) -25.91 Million SEK 100.88%
Saniona AB (publ) -69.69 Million SEK 100.327%
Lipigon Pharmaceuticals AB (publ) -12.1 Million SEK 101.884%
Biovica International AB (publ) -119.5 Million SEK 100.191%
Spago Nanomedical AB (publ) -42.22 Million SEK 100.54%
AcouSort AB (publ) -16.7 Million SEK 101.365%
Xintela AB (publ) -53.47 Million SEK 100.426%
Abliva AB (publ) -93.6 Million SEK 100.244%
Egetis Therapeutics AB (publ) -319.1 Million SEK 100.071%
Karolinska Development AB (publ) -26.78 Million SEK 100.851%
OncoZenge AB (publ) 7.26 Million SEK 96.862%
Amniotics AB (publ) -27.14 Million SEK 100.84%
2cureX AB (publ) -35.13 Million SEK 100.649%
CombiGene AB (publ) -35.33 Million SEK 100.645%
Asarina Pharma AB (publ) -14.21 Million SEK 101.604%
Calliditas Therapeutics AB (publ) -367.8 Million SEK 100.062%
Camurus AB (publ) 562.54 Million SEK 99.959%
Corline Biomedical AB -1.69 Million SEK 113.483%
IRLAB Therapeutics AB (publ) -173.32 Million SEK 100.132%
Isofol Medical AB (publ) -37.02 Million SEK 100.616%
I-Tech AB 30.34 Million SEK 99.249%
Hansa Biopharma AB (publ) -714.55 Million SEK 100.032%
Cyxone AB (publ) -20.41 Million SEK 101.117%
ExpreS2ion Biotech Holding AB (publ) -102.45 Million SEK 100.223%
Cantargia AB (publ) -284.31 Million SEK 100.08%
NextCell Pharma AB -40.98 Million SEK 100.556%
Xspray Pharma AB (publ) -169.81 Million SEK 100.134%
Elicera Therapeutics AB (publ) -17.08 Million SEK 101.335%
Nanologica AB (publ) -62.11 Million SEK 100.367%
SynAct Pharma AB -222.7 Million SEK 100.102%
Annexin Pharmaceuticals AB (publ) -43.86 Million SEK 100.52%
Stayble Therapeutics AB (publ) 309.41 Thousand SEK 26.312%
LIDDS AB (publ) -39.67 Million SEK 100.575%
Lipum AB (publ) -37.11 Million SEK 100.614%
BioInvent International AB (publ) -312.7 Million SEK 100.073%
Alzinova AB (publ) 41.99 Thousand SEK -442.87%
Oncopeptides AB (publ) -231.62 Million SEK 100.098%
Pila Pharma AB (publ) -8.81 Million SEK 102.587%
Guard Therapeutics International AB (publ) -114.9 Million SEK 100.198%
Scandinavian ChemoTech AB (publ) -19.57 Million SEK 101.165%
Simris Alg AB (publ) -22.36 Million SEK 101.02%
Diamyd Medical AB (publ) -140.85 Million SEK 100.162%
Xbrane Biopharma AB (publ) -282.03 Million SEK 100.081%
Ascelia Pharma AB (publ) -108.55 Million SEK 100.21%
Diagonal Bio AB (publ) -11.46 Million SEK 101.988%